A human ESC-based screen identifies a role for the translated lncRNA LINC00261 in pancreatic endocrine differentiation
- University of California, San Diego, United States
- Max-Delbruck-Center for Molecular Medicine, Germany
Abstract
Long noncoding RNAs (lncRNAs) are a heterogenous group of RNAs, which can encode small proteins. The extent to which developmentally regulated lncRNAs are translated and whether the produced microproteins are relevant for human development is unknown. Using a human embryonic stem cell (hESC)-based pancreatic differentiation system, we show that many lncRNAs in direct vicinity of lineage-determining transcription factors (TFs) are dynamically regulated, predominantly cytosolic, and highly translated. We genetically ablated ten such lncRNAs, most of them translated, and found that nine are dispensable for pancreatic endocrine cell development. However, deletion of LINC00261 diminishes insulin+ cells, in a manner independent of the nearby TF FOXA2. One-by-one deletion of each of LINC00261's open reading frames suggests that the RNA, rather than the produced microproteins, is required for endocrine development. Our work highlights extensive translation of lncRNAs during hESC pancreatic differentiation and provides a blueprint for dissection of their coding and noncoding roles.
Data availability
All mRNA-seq and Ribo-seq datasets generated for this study have been deposited at GEO under the accession number GSE144682.
-
The role of long noncoding RNAs during pancreas developmentNCBI Gene Expression Omnibus, GSE144682.
-
Illumina BodyMap 2.0NCBI Gene Expression Omnibus, GSE30611.
-
RNA-seq from ENCODE/CaltechNCBI Gene Expression Omnibus, GSE33480.
-
polyA mRNA RNA-seq from BE2C (ENCSR000BYK)NCBI Gene Expression Omnibus, GSE93448.
-
polyA mRNA RNA-seq from HepG2 (ENCSR329MHM)NCBI Gene Expression Omnibus, GSE90322.
-
polyA mRNA RNA-seq from Jurkat clone E61 (ENCSR000BXX)NCBI Gene Expression Omnibus, GSE93435.
-
polyA mRNA RNA-seq from Panc1 (ENCSR000BYM)NCBI Gene Expression Omnibus, GSE93450.
-
polyA mRNA RNA-seq from PFSK-1 (ENCSR000BYN)NCBI Gene Expression Omnibus, GSE93451.
-
polyA mRNA RNA-seq from U-87 MG (ENCSR000BYO)NCBI Gene Expression Omnibus, GSE90176.
Article and author information
Author details
Sebastiaan van Heesch
Funding
National Institutes of Health (DK068471 and DK078803)
- Maike Sander
Alexander von Humboldt-Stiftung
- Maike Sander
Larry L. Hillblom Foundation (2015-D-021-FEL)
- Bjoern Gaertner
European Molecular Biology Organization (ALTF 186-2015)
- Sebastiaan van Heesch
Horizon 2020 Framework Programme (AdG788970)
- Norbert Hübner
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2020, Gaertner et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,723
- views
-
- 371
- downloads
-
- 31
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
A human ESC-based screen identifies a role for the translated lncRNA LINC00261 in pancreatic endocrine differentiation
eLife 9:e58659.
https://doi.org/10.7554/eLife.58659
Further reading
-
- Computational and Systems Biology
- Genetics and Genomics
Root causal gene expression levels – or root causal genes for short – correspond to the initial changes to gene expression that generate patient symptoms as a downstream effect. Identifying root causal genes is critical towards developing treatments that modify disease near its onset, but no existing algorithms attempt to identify root causal genes from data. RNA-sequencing (RNA-seq) data introduces challenges such as measurement error, high dimensionality and non-linearity that compromise accurate estimation of root causal effects even with state-of-the-art approaches. We therefore instead leverage Perturb-seq, or high-throughput perturbations with single-cell RNA-seq readout, to learn the causal order between the genes. We then transfer the causal order to bulk RNA-seq and identify root causal genes specific to a given patient for the first time using a novel statistic. Experiments demonstrate large improvements in performance. Applications to macular degeneration and multiple sclerosis also reveal root causal genes that lie on known pathogenic pathways, delineate patient subgroups and implicate a newly defined omnigenic root causal model.
-
- Computational and Systems Biology
Artificial intelligence (AI) models have been used to study the compositional regularities of proteins in nature, enabling it to assist in protein design to improve the efficiency of protein engineering and reduce manufacturing cost. However, in industrial settings, proteins are often required to work in extreme environments where they are relatively scarce or even non-existent in nature. Since such proteins are almost absent in the training datasets, it is uncertain whether AI model possesses the capability of evolving the protein to adapt extreme conditions. Antibodies are crucial components of affinity chromatography, and they are hoped to remain active at the extreme environments where most proteins cannot tolerate. In this study, we applied an advanced large language model (LLM), the Pro-PRIME model, to improve the alkali resistance of a representative antibody, a VHH antibody capable of binding to growth hormone. Through two rounds of design, we ensured that the selected mutant has enhanced functionality, including higher thermal stability, extreme pH resistance, and stronger affinity, thereby validating the generalized capability of the LLM in meeting specific demands. To the best of our knowledge, this is the first LLM-designed protein product, which is successfully applied in mass production.
